Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product

NCT02840110 · clinicaltrials.gov ↗

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

B Cell Lymphomas
Multiple Myeloma
Solid Tumor
HER-2 Protein Overexpression

Interventions

OTHER: ACTR T Cell Product

Sponsor

Cogent Biosciences, Inc.